Search results

From Self-sufficiency
Jump to: navigation, search
  • | group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists|α<sub>2</sub> agonist]] | group3 = [[Imidazoline receptor]] agonist
    2 KB (200 words) - 12:10, 19 September 2010
  • * [[Receptor (biochemistry)|Receptor]]: [[Receptor agonist|Agonist]]{{•}} [[Receptor antagonist|Antagonist]]{{•}} [[Positive allosteric modulator]] (PAM){{• | group3 = [[Receptor (biochemistry)|Receptor]] &<br/>[[Membrane transport protein|transporter]]
    4 KB (375 words) - 12:11, 19 September 2010
  • | group1 = [[Cholecystokinin A receptor|CCK<sub>A</sub>]] | group2 = [[Cholecystokinin A receptor|CCK<sub>B</sub>]]
    9 KB (713 words) - 12:11, 19 September 2010
  • ...ltryptamine|α,N,N-TMT]]{{•w}} [[alpha-Ethyltryptamine|α-ET]]{{•w}} [[alpha-Methyltryptamine|α-MT]]{{•w}} [[AL-37350A]]{{•w}} [[Baeocystin]]{{•w ...(Racemorphan); <br/>'''Others:''' [[3-amino-2-methyl-1,1-di(phenyl)propan-1-ol|2-MDP]]{{•w}} [[8a-Phenyldecahydroquinoline|8A-PDHQ]]{{•w}} [[Aptiga
    11 KB (1,039 words) - 12:11, 19 September 2010
  • |IUPAC_name=''7-Chloro- 1,3-dihydro- 3-hydroxy- 1-methyl- 5-phenyl- 1,4-benzodiazepin- 2-one'' |C=16 |H=13 |Cl=1 |N=2 |O=2
    45 KB (6,129 words) - 22:16, 19 September 2010
  • ...t to it, [[diabetes mellitus|diabetes]] occurs. Glucagon, secreted by the alpha cells of the pancreas, helps the body utilise stored [[glycogen]] or conver ...ly. Mutation of it has resulted in [[Crohn's disease]]. Excessive T-helper 1 responses to resident flora in the gut are controlled by inhibiting the con
    21 KB (3,070 words) - 21:41, 19 September 2010
  • | IUPAC_name = 3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1''H''-purine-2,6-dione | elimination_half-life = 0.4 - 0.8 hours (1 - 1.6 hours for active metabolite)
    7 KB (885 words) - 09:43, 20 September 2010
  • | C=9 | H=9 | Br=1 | F=1 | N=3 ...rinary Medicine A. Physiology, Pathology, Clinical Medicine''. 2007 Feb;54(1):48-50. PMID 17359455</ref><ref>Belda E, Laredo FG, Escobar M, Soler M, Luc
    3 KB (435 words) - 13:12, 20 September 2010
  • | IUPAC_name = 4-(1-naphthalen- 1-ylethyl)- 1H-imidazole ...atents?id=MLUiAAAAEBAJ&dq=5151526 Fu-Lian Hsu and William P. Ashman. 4-(1-(1-naphthalenyl)ethyl)- 1H- imidazole, method of making and use as an anesthet
    3 KB (495 words) - 13:13, 20 September 2010
  • ...&#x200b;dimethylphenyl)-&#x200b;5,6-&#x200b;dihydro-&#x200b;4''H''-&#x200b;1,3-&#x200b;thiazin-&#x200b;2-&#x200b;amine | C=12 | H=16 | N=2 | S=1
    3 KB (361 words) - 13:13, 20 September 2010
  • | IUPAC_name = 5-Bromo-''N''-(4,5-dihydro-1''H''-imidazol-2-yl) quinoxalin-6-amine | C=11 | H=10 | Br=1 | N=5
    2 KB (237 words) - 13:13, 20 September 2010
  • | IUPAC_name = (''S'')-4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole | InChI = 1/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1
    6 KB (747 words) - 13:13, 20 September 2010
  • -4,5-dihydro-1''H''-imidazole ...ed under many brand names (see below), with the typical adult dose being 0.1% [[w/v]] xylometazoline, and the dose for children under 12 being 0.05%.{{F
    3 KB (395 words) - 13:14, 20 September 2010
  • ...3N3/c1-14-6-8-18(16(3)10-14)20-12-22(5)13-21-19-9-7-15(2)11-17(19)4/h6-13H,1-5H3/b20-12+,21-13+ | CASNo=33089-61-1
    3 KB (393 words) - 13:14, 20 September 2010
  • | IUPAC_name = [(1S,3S,5S,7S)-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenyl-propanoate | InChI = 1/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-1
    2 KB (273 words) - 13:14, 20 September 2010
  • ...b-hydroxy-2-methyl- 3,6-dioxooctahydro-2''H''-oxazolo[3,2-''a''] pyrrolo[2,1-''c'']pyrazin-2-yl) -7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-''fg''] quin ...-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1
    7 KB (986 words) - 13:14, 20 September 2010
  • | IUPAC_name = (''RS'')-4-[1-(2,3-dimethylphenyl)ethyl]-3''H''-imidazole | imagename = 1 : 1 mixture (racemate)<br />
    6 KB (885 words) - 13:14, 20 September 2010
  • | IUPAC_name = 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1''H''-imidazole ...ction in reducing swelling when applied to [[mucous membrane]]. It acts on alpha-receptors in the [[arterioles]] of the [[conjunctiva]] to produce constrict
    3 KB (391 words) - 13:14, 20 September 2010
  • | IUPAC_name = 4-[1-hydroxy-2-(methylamino)ethyl]phenol | C=9|H=13|N=1|O=2
    7 KB (919 words) - 13:14, 20 September 2010
  • | IUPAC_name = (''R'')-3-[-1-hydroxy-2-(methylamino)ethyl]phenol | C=9 | H=13 | N=1 | O=2 |
    13 KB (1,712 words) - 13:15, 20 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)